Loading data
CGONNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Research and development expense | 116.64 m USD | 82.1 m USD | 45.75 m USD |
| Operating profit | -190.77 m USD | -114.67 m USD | -55.45 m USD |
| Income tax expense | -270 k USD | 1 k USD | 1 k USD |
| Net income (reported basis) | -161 m USD | -88.04 m USD | -48.61 m USD |
| Net income attributable to common shareholders | -161 m USD | -88.04 m USD | -67.8 m USD |
| Basic earnings per share | -2.08 USD/share | -1.41 USD/share | -15.65 USD/share |
| Diluted earnings per share | -2.08 USD/share | -1.41 USD/share | -15.65 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.